Michael Kaseta Liquidia Corp (LQDA) insider trading activity

Michael Kaseta is CFO and COO of Liquidia Corp. Currently has a direct ownership of 353,823 shares of LQDA, which is worth approximately $10.1 Million. The most recent transaction as insider was on Dec 01, 2025, when has been sold 1,166 shares (Common Stock) at a price of $32.19 per share, resulting in proceeds of $37,533. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 354K

1.29% 3M change

13.29% 12M change

Total Value Held $10.1 Million

Michael Kaseta Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2025	SELL Open market or private sale	$37,533 $32.19 p/Share	1,166 Reduced 0.33%	353,823 Common Stock
Nov 28 2025	BUY Exercise of conversion of derivative security	-	2,343 Added 0.66%	354,989 Common Stock
Oct 13 2025	SELL Open market or private sale	$272,258 $23.41 p/Share	11,630 Reduced 3.19%	352,646 Common Stock
Oct 10 2025	BUY Exercise of conversion of derivative security	-	5,828 Added 1.57%	364,276 Common Stock
Sep 02 2025	SELL Open market or private sale	$33,349 $29.05 p/Share	1,148 Reduced 0.32%	358,448 Common Stock
Aug 29 2025	BUY Exercise of conversion of derivative security	-	2,344 Added 0.65%	359,596 Common Stock
Aug 15 2025	SELL Open market or private sale	$523,600 $26.18 p/Share	20,000 Reduced 5.31%	356,412 Common Stock

Aug 05 2025	SELL Open market or private sale	$600,000 $20.0 p/Share	30,000 Reduced 7.38%	376,412 Common Stock
Jul 14 2025	SELL Open market or private sale	$165,362 $14.28 p/Share	11,580 Reduced 2.77%	406,412 Common Stock
Jul 11 2025	BUY Exercise of conversion of derivative security	-	5,828 Added 1.38%	417,992 Common Stock
Jun 04 2025	SELL Open market or private sale	$250,765 $16.97 p/Share	14,777 Reduced 3.46%	412,164 Common Stock
Jun 03 2025	BUY Exercise of conversion of derivative security	-	29,141 Added 6.39%	426,941 Common Stock
Jun 02 2025	SELL Open market or private sale	$14,379 $16.74 p/Share	859 Reduced 0.22%	397,800 Common Stock
May 30 2025	BUY Exercise of conversion of derivative security	-	2,344 Added 0.58%	398,659 Common Stock
Apr 14 2025	SELL Open market or private sale	$112,400 $13.57 p/Share	8,283 Reduced 2.05%	396,315 Common Stock
Mar 03 2025	SELL Open market or private sale	$13,503 $15.45 p/Share	874 Reduced 0.22%	404,598 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	2,344 Added 0.57%	405,472 Common Stock
Jan 14 2025	SELL Open market or private sale	$275,298 $11.78 p/Share	23,370 Reduced 5.5%	401,755 Common Stock
Jan 11 2025	BUY Grant, award, or other acquisition	-	112,797 Added 20.97%	425,125 Common Stock
Dec 02 2024	SELL Open market or private sale	$12,557 $11.51 p/Share	1,091 Reduced 0.35%	312,328 Common Stock
Nov 30 2024	BUY Exercise of conversion of derivative security	-	2,343 Added 0.74%	313,419 Common Stock
Oct 14 2024	SELL Open market or private sale	$43,240 $11.11 p/Share	3,892 Reduced 1.24%	311,076 Common Stock
Sep 03 2024	SELL Open market or private sale	$10,250 $9.5 p/Share	1,079 Reduced 0.34%	314,968 Common Stock
Aug 30 2024	BUY Exercise of conversion of derivative security	-	2,344 Added 0.74%	316,047 Common Stock
Jul 12 2024	SELL Open market or private sale	$48,942 $12.53 p/Share	3,906 Reduced 1.23%	312,389 Common Stock

Also insider at

ALIM

ALIMERA SCIENCES INC Healthcare

Director

HRTX

HERON THERAPEUTICS, INC. Healthcare

Michael Kaseta

CFO and COO

Morrisville, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LQDA shares.

Notify only if

Value

Insider Trading

Get notified when an Liquidia Corp insider buys or sells LQDA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Liquidia Corp

Track Activities on LQDA

Account